Toggle light / dark theme

Waymo strikes deals with Walmart, others to boost access to self-driving cars

Why cant they just put the groceries in the car and let it drive itself there and back.


In partnerships with five companies, including Walmart, Autonation and Avis, Waymo autonomous vehicles will pick up customers and drive them to various locations in the Phoenix area. In some cases, customers will be offered savings or deals in order to be shuttled around in Waymo vehicles.

“We’ve tailored our partnerships to meet the top rider needs; in fact, the partnerships below represent eight of the top ten activities our riders do when they get in a Waymo,” the company wrote in a blog post announcing the partnerships.

Here are the company specific rides Waymo will be providing customers:

Could We Use Space to Pay for a Universal Basic Income?

Universal basic income is a generous idea in principle, with clear benefits to society. However, the question of how to pay for it remains an enigma. While some propose taxation, others think we should use the booming space trade to benefit us all.

Universal basic income is the idea that every citizen should receive an amount of money from the government to meet their needs, regardless of age, race, gender, or even need. It has been billed as a solution to a variety of current and potential societal problems, including AI automation, poverty, and people losing the ability to allocate their own time.

How Is AI Used In Healthcare — 5 Powerful Real-World Examples That Show The Latest Advances

Healthcare can be transformed with the innovation and insights of AI and machine learning. From robot-assisted surgery to virtual nursing assistants, diagnosing conditions facilitating workflow and analyzing images, AI and machines can help improve outcomes for patients and lower costs for providers.

Dr. Aubrey de Grey – SENS Research Foundation

It’s almost the weekend and what better way to celebrate than a nice long interview with one of the Heroes of aging research? Today we bring you a mega-interview with Dr. Aubrey de Grey.


Today we have an interview with Dr. Aubrey de Grey from the SENS Research Foundation. This interview conducted by Yuri Deigin was originally published in Russian language and he has kindly translated it into English so our audience can enjoy it too.

Yuri: Aubrey, thank you very much for agreeing to this interview. Why don’t we dive right in? I am sure everybody asks you this: how and when did you become interested in aging, and when did you decide to make it your life’s mission to defeat it?

Aubrey de Grey: I became interested in aging and decided to work on it in my late 20s, so, in the early 1990s. The reason I became interested was because that was when I discovered that other biologists were almost all not interested in it. They did not think that aging was a particularly important or interesting question. I had always assumed, throughout my whole life, that aging was obviously the world’s most important problem. I thought that people who understood biology would be working on it really hard. Then, I discovered that wasn’t true and that hardly any biologists were working on it. The ones that were weren’t doing it very well, not very productively as far as I could see. I thought I’d better have a go myself, so I switched fields from my previous research area, which was artificial intelligence.

How artificial intelligence is changing the pharmaceutical industry

But the great potential of artificial intelligence shall become fully clear when considering its possible applications to drug discovery. It seems an era ago since the Human Genome Project was completed in 2003; since then, sequencing capabilities and softwares for data analysis rapidly established themselves as the new paradigm for drug discovery thanks to the increasing availability of IT technologies and the institutional and governmental support to big data analytics’ policies.

The exponential growth of the market

The annual growth rate of the market of artificial intelligence for healthcare applications has been recently estimated by Global Market Insights to be 40% CAGR (Compounded Average Growth Rate) per year up to 2024, starting from a value on $ 750 million in 2016.

/* */